Renal artery stenosis
Also known as: Renal arterial stenosis, Renal artery narrowing, Atherosclerotic renal artery stenosis, Renovascular disease
Renal artery stenosis (RAS) is the narrowing of one or both renal arteries, predominantly secondary to atherosclerosis or fibromuscular dysplasia. Pathophysiological consequences include renovascular hypertension, compromised renal function, and acute cardiovascular instability, necessitating rigorous medical evaluation and specialist intervention. Traditional Chinese Medicine (TCM) acts solely as an adjunctive modality for symptom management; it does not substitute for diagnostic imaging, pharmacological therapy, or surgical revascularisation, and possesses no mechanism to resolve arterial stenosis. The current evidence base is insufficient to establish acupuncture's efficacy: cited literature includes a trial protocol for hypertension, a case report involving ozone-neurolysis, and observational data. Although fluctuations in inflammatory markers were recorded during multimodal care, these findings do not validate TCM as a sufficient or effective diagnostic or therapeutic tool for RAS.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain a systematic log of blood pressure and associated symptoms using a validated brachial cuff monitor, adhering to the schedule prescribed by the clinical team.
- •Consult a medical practitioner or renal dietitian regarding sodium restriction; potassium-based salt substitutes must be avoided unless explicitly cleared by a specialist.
- •Utilise professional smoking cessation resources and maintain a physical activity regimen within established cardiovascular and renal safety parameters.
- •Bring all medications, supplements, and herbal products to reviews; check with a medical practitioner before using NSAIDs, decongestants, or liquorice-containing products.
Cautions & Contraindications
- •Do not use acupuncture or herbs instead of structural vascular assessment, renal monitoring or prescribed hypertension treatment. The supplied TCM-SPECT study explicitly describes complementary assessment, and its uncontrolled combined-treatment findings cannot justify withdrawing medicines.[]
- •Do not extrapolate the essential-hypertension acupuncture protocol to proven efficacy or safety in renovascular hypertension. Defer treatment during unstable pressure, acute illness or suspected organ injury; these deferral precautions are clinical safeguards rather than outcomes established by the protocol.[]
- •Do not offer ozone injection or renal-region neurolysis as routine TCM care on the basis of a single case. That report describes renal artery stenosis as a contraindication to catheter-based renal denervation; procedural eligibility belongs with specialist teams.[]
- •Pregnancy, anticoagulation, advanced renal impairment and planned vascular procedures require individual needling and herbal risk review. The supplied studies do not establish safety in these populations; observational improvements during combined care are not evidence that herbal prescribing is safe for them.[,]
When to reassess or seek care again
For medically stable patients choosing adjunctive care, review after 2 weeks and again by 4 weeks. Record home blood pressure trends, dizziness or headache frequency, sleep disturbance, a 0–10 symptom score and adverse effects. The treating medical team determines creatinine/eGFR and electrolyte monitoring, particularly after medicine changes or any herbal exposure. Stop or reconsider adjunctive treatment if there is no meaningful symptom benefit by 4 weeks. Escalate sooner for readings outside the agreed plan, symptomatic low pressure, worsening renal results or new swelling; emergency features require immediate care.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- PloS one · 2025
- JACC. Case reports · 2026
- Frontiers in cardiovascular medicine · 2026
- Frontiers in medicine · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
